| TGA Action ID |
RC-2026-RN-00470-1 |
| Type of Product |
Medical Device |
| Product Name/Description |
HemosIL AcuStar ADAMTS13 Activity. An in vitro diagnostic medical device (IVD).
Part Number: 0009802048
Lot Numbers: B37916, B38144, B40093
Expiry Dates: 2026-09-01, 2026-12-16, 2027-03-01 |
| ARTG Number |
191094 |
| Unique Device Identifier (UDI) |
08426950602422 |
| Action Type |
Product Correction |
| Action Level |
Hospital |
| Hazard Classification |
Class II |
| Reason for the Action |
Customer complaints have reported that the HemosIL AcuStar ADAMTS13 Activity assay does not meet its labelled on-board stability claim of 56 days at 2-8°C on the ACL AcuStar system across multiple lots.
Internal testing has demonstrated an increase in measured ADAMTS13 activity at the 10% medical decision level (MDL), with values observed to exceed the established acceptance criteria by up to 0.6%.
An internal investigation has identified a previously unrecognised problem whereby erroneously high patient results may occur after extended on-board use, while quality control results may remain within acceptable limits. |
| Instructions for Customers/Users |
Customers should:
1. Identify all stock of this product, particularly if already on-board an ACL AcuStar system. 2. Immediately use the reduced on-board instrument stability claim of 28 days at 2-8°C for all current and future lots of this product. 3. Run quality controls in accordance with the labelled instructions for use.
Note that the on-board instrument stability claim in the Instructions for Use will be updated in future lots of HemosIL AcuStar ADAMTS13 Activity.
Until this update is implemented, lots will be distributed with a sticker indicating the reduced 28-day indicating the reduced 28-day on-board stability claim on the ACL AcuStar system.
This action has been closed out on 27/10/2026 |
| Action Commencement Date |
22/06/2026 |
| Responsible Entity |
|
| Contact Information |
1300 369 132 - Sponsor Customer Service |